Refine
Year of publication
Document Type
- Article (409)
- Preprint (215)
- Contribution to a Periodical (8)
- Conference Proceeding (6)
- Working Paper (6)
- Book (1)
- Report (1)
Has Fulltext
- yes (646)
Is part of the Bibliography
- no (646)
Keywords
- e +-e − Experiments (12)
- BESIII (11)
- Branching fraction (8)
- Particle and Resonance Production (6)
- Charm Physics (5)
- Spectroscopy (5)
- Heavy-ion collisions (4)
- Lepton colliders (4)
- Quarkonium (4)
- portal hypertension (4)
- stochastic differential utility (4)
- COVID-19 (3)
- Charmed mesons (3)
- Diffraction (3)
- Elastic scattering (3)
- Electroweak interaction (3)
- Exotics (3)
- Hadronic decays (3)
- Polarization (3)
- e+-e− Experiments (3)
- Beam Energy Scan (2)
- Biomarkers (2)
- Branching fractions (2)
- Brassica napus (2)
- COVID-19 surveillance (2)
- Cancer (2)
- Charm physics (2)
- Charmonium (2)
- Chiral Magnetic Effect (2)
- Collectivity (2)
- Correlation (2)
- Electroweak Interaction (2)
- Epidemiology (2)
- FBSDE (2)
- Flavour Physics (2)
- Immunology (2)
- Leptonic, semileptonic & radiative decays (2)
- Mechanisms of disease (2)
- Mitochondria (2)
- Non-small cell lung cancer (2)
- Omicron (2)
- Particle decays (2)
- RHIC (2)
- Radiative decay (2)
- Radiotherapy (2)
- Rare diseases (2)
- Registries (2)
- SARS-CoV-2 (2)
- SARS-CoV-2 monitoring (2)
- STAR (2)
- Shear viscosity (2)
- Treatment (2)
- asset pricing (2)
- cirrhosis (2)
- consumption-portfolio choice (2)
- incomplete markets (2)
- microdosing (2)
- recursive utility (2)
- 140Ce (1)
- 3years (1)
- ACLF (1)
- ADGRE1 (1)
- AIS (1)
- ALK (1)
- ALK-rearranged NSCLC (1)
- ARDS (1)
- ATM (1)
- Acuris (1)
- Acute elbow dislocation (1)
- Advanced biliary tract cancer (1)
- Alpha-synuclein (1)
- Alternative oxidase (1)
- Antibiotic therapy (1)
- Antirheumatic agents (1)
- Araneae (1)
- Artificial Intelligence (1)
- Augenerkrankungen (1)
- Autosomal recessive cutis laxa type 1C (1)
- B-slope (1)
- B.1.1.529 (1)
- BA.4 (1)
- BA.5 (1)
- BESIII detector (1)
- BI1361849 (1)
- BTC (1)
- Bacterial leakage (1)
- Beam energy scan (1)
- Bhabha (1)
- Biodiversity Data (1)
- Biogeography (1)
- Biomedical engineering (1)
- Biomonitoring (1)
- Bipolar disorder (1)
- Born cross section (1)
- Born cross section measurement (1)
- Botanical Collections (1)
- Branching fraction measurement (1)
- CAD/CAM crown (1)
- CAKUT (1)
- CBA (1)
- CEP68 (1)
- COMP (1)
- COVID 19 (1)
- CP violation (1)
- CRVO (1)
- CV9202 (1)
- Cardiac implantable electronic devices (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy (1)
- Cardiovascular disease risk (1)
- Cardiovascular diseases (1)
- Cement gap (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charm vector (1)
- Charmonia (1)
- Charmonium (-like) (1)
- Chest pain unit (1)
- Child (1)
- Chiral magnetic effect (1)
- Circadian (1)
- Cirrhosis (1)
- Classification (1)
- Clinical trial (1)
- Coalescence (1)
- Cognitive impairment (1)
- Cohort studies (1)
- Cold nuclear matter effects (1)
- Colorectal cancer (1)
- Comparative effectiveness research (1)
- Complex II (1)
- Concept paper (1)
- Conometric connection (1)
- Consensus (1)
- Consensus document (1)
- Conservation (1)
- Consumption hump (1)
- Coronary intervention (1)
- Critical care (1)
- Critical point (1)
- Cross section (1)
- D meson (1)
- DME (1)
- DNA-PK (1)
- Dark photon (1)
- Dark sector (1)
- Data Standard (1)
- Data protection (1)
- Data sharing (1)
- Datenschutz (1)
- Dermatomyositis (1)
- Detection workflow (1)
- Deuteron production (1)
- Deutschland (1)
- Di-hadron correlations (1)
- Diagnosis (1)
- Digital (1)
- Digitization (1)
- ECM (1)
- EMR1 (1)
- Ecology (1)
- Ecophysiology (1)
- Ectoparasites (1)
- Education (1)
- Effective form factor (1)
- Einwanderer (1)
- Elastogenesis (1)
- Electromagnetic form factor (1)
- Electromagnetic form factors (1)
- Electromagnetic transitions (1)
- Elliptic flow (1)
- Equity (1)
- Etanercept (1)
- Exercise training (1)
- Experimental nuclear physics (1)
- Experimental particle physics (1)
- Extracellular matrix (1)
- Eye diseases (1)
- EyesiNet (1)
- F4/80 (1)
- FOS: Physical sciences (1)
- Fibulin-4 (1)
- Fibulin-5 (1)
- Flavor changing neutral currents (1)
- Flavor symmetries (1)
- Flow (1)
- Form factors (1)
- Forward physics (1)
- Fracture type (1)
- Fremdbild (1)
- GLM (1)
- Genetics (1)
- Genetics research (1)
- Geschichte 1981-1997 (1)
- Gomphus flavipes (1)
- Groomed jet radius (1)
- HCC (1)
- Hadron-Hadron scattering (experiments) (1)
- Hadronization (1)
- Hand-foot syndrome (1)
- Hantavirus (1)
- Health information (1)
- Health-seeking behaviour (1)
- Heart failure (1)
- Heavy Ion Experiments (1)
- Heavy Quark Production (1)
- Heavy ion collisions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-ion (1)
- Helicity amplitude analysis (1)
- Helpline (1)
- Herbaria (1)
- Hif1α (1)
- High Energy Physics - Experiment (hep-ex) (1)
- Higher moments (1)
- Hyperons (1)
- Hypertension (1)
- Hypofractionated radiotherapy (1)
- ICU (1)
- IHMCIF (1)
- IL-6 (1)
- ILUVIEN (1)
- IR (1)
- ISS (1)
- Immunogenetics (1)
- Immunomonitoring (1)
- Implantable cardioverter-defibrillator (1)
- Inclusive branching fraction (1)
- Inflammation (1)
- Initial state radiation (1)
- Integrative Modeling (1)
- Interference fragmentation function (1)
- Invisible decays (1)
- J/ψ suppression (1)
- Jet substructure (1)
- K0S (1)
- K3EDTA plasma sampling (1)
- K48-linked (1)
- K63-linked (1)
- Konzeptpapier (1)
- Landscape ecology (1)
- Landschaftsökologie (1)
- Latent transforming growth factor β-binding protein 4 (1)
- Lehre (1)
- Libellen (1)
- Lifestyle (1)
- Lipidomics (1)
- Liver diseases (1)
- Ltbp-4 (1)
- Ltbp-4L (1)
- Ltbp-4S (1)
- L´evy framework (1)
- MACS (1)
- MCP-1 (1)
- MMPs (1)
- MRSA (1)
- MYCN amplification (1)
- Marginal integrity (1)
- Metabolomics (1)
- Microgap (1)
- Mitochondrial disease (1)
- Models & methods for nuclear reactions (1)
- Molecular diagnostic testing (1)
- Molecular medicine (1)
- Multiple parton interactions (1)
- Multivariate analysis (1)
- Myotis myotis (1)
- NAFLD (1)
- NET (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- NMR spectroscopy (1)
- NSCLC (1)
- NSTEMI (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Netzhaut (1)
- Neutrinos (1)
- Neutron physics (1)
- Nonflow (1)
- Nuclear reactions (1)
- Nutzen (1)
- Oncogenes (1)
- Open Access (1)
- Ophiogomphus cecilia (1)
- Orphan disease (1)
- Osteoporosis (1)
- Outcome (1)
- Oxidative phosphorylation (1)
- PBSC (1)
- PDB-Dev (1)
- PDBx/mmCIF (1)
- PDE‐5‐inhibitor (1)
- PDGFRβ (1)
- PI3K (1)
- PRRT (1)
- PTEN (1)
- Pacemaker (1)
- Parkinson disease (1)
- Parkinson’s disease (1)
- Particle and resonance production (1)
- Particle phenomena (1)
- Patient safety (1)
- Periodontal disease (1)
- Periodontal therapy (1)
- Pest-crop interactions (1)
- Phalangeal fractures (1)
- Physical activity (1)
- Plasminogen (1)
- Platelets (1)
- Pneumonia (1)
- Portal veins (1)
- Poverty (1)
- Pre-analytics (1)
- Preclinical research (1)
- Predictive markers (1)
- Prevention (1)
- Prognosis (1)
- Prognostic models (1)
- Prostaglandin (1)
- Proton (1)
- Proton-proton collisions (1)
- Proton–proton collisions (1)
- Psychiatric disorders (1)
- Psychiatry (1)
- Puumala virus (1)
- QCD (1)
- Quantum chromodynamics (1)
- RAS pathway (1)
- RNA (1)
- RNA-binding proteins (1)
- Radiative capture (1)
- Rapps (1)
- Rare decays (1)
- Real world (1)
- Register (1)
- Remission (1)
- Research Infrastructure (1)
- Resonance reactions (1)
- Respiratory chain (1)
- Retina (1)
- Retro-IDEAL (1)
- Rh(II) catalysis (1)
- Rheumatoid arthritis (1)
- Rodent-associated infections (1)
- Roosting place (1)
- SARS CoV 2 (1)
- SD-OCT (1)
- SLC20A1 (1)
- SPSS (1)
- STED superresolution (1)
- Sampling protocol (1)
- Schulbuch (1)
- Schädling (1)
- Seasonal variation (1)
- Seltene Erkrankungen (1)
- Semantics (1)
- Semi-leptonic decays (1)
- Single-molecule biophysics (1)
- Social determinants (1)
- SoftDrop (1)
- Solar insolation (1)
- Sorafenib (1)
- Spatial scales (1)
- Spatio-temporal patterns (1)
- Spin alignment (1)
- Spine care (1)
- Spinturnix myoti (1)
- Splitting function (1)
- Standardization (1)
- Staphylococcus aureus (1)
- Stentoplasty (1)
- Steroid (1)
- Student (1)
- Suicide (1)
- Sunlight (1)
- Super-resolution microscopy (1)
- Surgical oncology (1)
- TACE (1)
- TGR(mREN2)27 (1)
- TP53 mutation status (1)
- Taxonomy (1)
- Techniques Electromagnetic calorimeters (1)
- Telemedicine (1)
- Thermal model (1)
- Thoracic trauma (1)
- Threshold effect (1)
- Thrombosis (1)
- Thromboxane (1)
- Transversity (1)
- UWB diagnostics (1)
- VEGF (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Variant of concern (1)
- Veins (1)
- Vertebral augmentation (1)
- Vertebral body stenting (1)
- Vertebral fracture (1)
- Vitreous samples (1)
- Wastewater-based epidemiology (WBE) (1)
- Western diet (1)
- Worldwide Protein Data Bank (1)
- X-ray crystallography (1)
- Y states (1)
- accessory proteins (1)
- acute decompensation (1)
- acute myeloid leukemia (1)
- acute-on-chronic liver failure (1)
- adaptive cardiac remodelling (1)
- adverse events (1)
- alternative oxidase (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- autoantibodies (1)
- azaindole (1)
- backward stochastic differential equation (1)
- bioactivity testing (1)
- bladder exstrophy-epispadias complex (1)
- bleomycin (1)
- bundle (1)
- c-kit (1)
- capture (1)
- cardiac ischaemia‐reperfusion (1)
- cartilage (1)
- cell stress (1)
- cell-free protein synthesis (1)
- center-of-mass energy (1)
- centrosome (1)
- centrosome linker (1)
- cerium (1)
- certainty equivalents (1)
- charmonium-like states (1)
- cloacal malformation (1)
- complications (1)
- computed tomography (1)
- consumption hump (1)
- convergence (1)
- cross-section (1)
- cytarabine dose (1)
- diabetic macular edema (1)
- diazo compounds (1)
- dimuon (1)
- dynamic programming (1)
- e+e − annihilation (1)
- e+e⁻ − Experiments (1)
- e+e− Experiments (1)
- easyPACId (1)
- ectosomes (1)
- education (1)
- elderly (1)
- electron transport chain (1)
- electron-positron collision (1)
- epigeic spiders (1)
- epigäische Spinnen (1)
- erectile dysfunction (1)
- exosomes (1)
- extracellular vesicles (1)
- fibrogenesis (1)
- fixed point approach (1)
- fluocinolone acetonide (1)
- fluorescent dye (1)
- functional genetics (1)
- generalist predators (1)
- generalistische Prädatoren (1)
- geriatric medicine (1)
- global change (1)
- guidelines (1)
- habit formation (1)
- habitat destruction (1)
- hadron spectroscopy (1)
- hadronic events (1)
- health information exchange (1)
- heavy-ion collisions (1)
- helicity amplitude analysis (1)
- hematotoxicity (1)
- hepatic encephalopathy (1)
- hepatic stellate cells (1)
- hepatocellular cancer (1)
- high-risk neuroblastoma (1)
- immunity (1)
- impatience (1)
- in vitro models (1)
- inclusive J/ψ decays (1)
- inflammation (1)
- intrinsically disordered region (1)
- jumps (1)
- kidney formation (1)
- land use (1)
- leisure (1)
- life-cycle utility maximization (1)
- liver (1)
- liver fibrosis (1)
- mRNA active cancer immunotherapy (1)
- macrophage (1)
- metallo β lactamases (1)
- microparticles (1)
- microvesicles (1)
- microwave ablation (1)
- microwave breast imaging (1)
- minimal information requirements (1)
- mouse (1)
- mouse model (1)
- multiresistant bacteria (1)
- n_TOF (1)
- natural products (1)
- nematophin (1)
- neuroendocrine tumor (1)
- neutralizing antibodies (1)
- neutron (1)
- nonstructural proteins (1)
- non‐selective beta‐blocker (1)
- normalization (1)
- nucleosynthesis (1)
- number of J/ψ events (1)
- optimal investment (1)
- osteoarthritis (1)
- oval split ring resonator (1)
- p+p collisions (1)
- p53 pathway (1)
- patient study (1)
- peptide receptor radionuclide therapy (1)
- peripheral blood stem cell collection (1)
- polyubiquitin (1)
- portosystemic shunt (1)
- prevention (1)
- primary biliary cholangitis (1)
- proteobacteria (1)
- qualitative research (1)
- quality control (1)
- rare diseases (1)
- reactive oxygen species (1)
- renin-angiotensin system (1)
- reproducibility (1)
- resectability (1)
- rigor (1)
- rootletin (1)
- s-process (1)
- second line therapy (1)
- sequential ALK-inhibitor therapy (1)
- simplified production (1)
- sorafenib (1)
- sphingolipid sphingosine-1-phosphate (1)
- sphingolipids (1)
- sphingosine-1-phosphate receptor 5 (1)
- spike protein (1)
- spontaneous portosystemic shunt (1)
- standardization (1)
- steatosis (1)
- stochastic volatility (1)
- structural proteins (1)
- surgery (1)
- systemic sclerosis (1)
- tetraquark (1)
- theranostics (1)
- thiol inhibitors (1)
- thrombospondins (1)
- treatment (1)
- treatment response (1)
- trigger efficiency (1)
- ubiquitin-conjugating enzymes (1)
- urinary tract development (1)
- ursodeoxycholic acid (1)
- variant of concern (1)
- variants of concern (1)
- wage hump (1)
- wastewater-based epidemiology (WBE) (1)
- welfare loss (1)
- wwPDB (1)
- zebrafish development (1)
- Λ+c baryon (1)
- Σ hyperon (1)
- Υ suppression (1)
- ψ(3686) (1)
- fibrogenesis (1)
Institute
- Physik (376)
- Frankfurt Institute for Advanced Studies (FIAS) (106)
- Medizin (91)
- Geowissenschaften (23)
- Präsidium (8)
- Biochemie und Chemie (7)
- Biochemie, Chemie und Pharmazie (7)
- Biowissenschaften (7)
- Wirtschaftswissenschaften (7)
- Center for Financial Studies (CFS) (6)
Using 10.1 × 109 J/ψ events produced by the Beijing Electron Positron Collider (BEPCII) at a center-of-mass energy √s = 3.097 GeV and collected with the BESIII detector, we present a search for the rare semi-leptonic decay J/ψ → D−e+νe + c.c. No excess of signal above background is observed, and an upper limit on the branching fraction ℬ(J/ψ → D−e+νe + c. c.) < 7.1 × 10−8 is obtained at 90% confidence level. This is an improvement of more than two orders of magnitude over the previous best limit.
Though immensely successful, the standard model of particle physics does not offer any explanation as to why our Universe contains so much more matter than antimatter. A key to a dynamically generated matter–antimatter asymmetry is the existence of processes that violate the combined charge conjugation and parity (CP) symmetry1. As such, precision tests of CP symmetry may be used to search for physics beyond the standard model. However, hadrons decay through an interplay of strong and weak processes, quantified in terms of relative phases between the amplitudes. Although previous experiments constructed CP observables that depend on both strong and weak phases, we present an approach where sequential two-body decays of entangled multi-strange baryon–antibaryon pairs provide a separation between these phases. Our method, exploiting spin entanglement between the double-strange Ξ− baryon and its antiparticle2 Ξ¯+
, has enabled a direct determination of the weak-phase difference, (ξP − ξS) = (1.2 ± 3.4 ± 0.8) × 10−2 rad. Furthermore, three independent CP observables can be constructed from our measured parameters. The precision in the estimated parameters for a given data sample size is several orders of magnitude greater than achieved with previous methods3. Finally, we provide an independent measurement of the recently debated Λ decay parameter αΛ (refs. 4,5). The ΛΛ¯
asymmetry is in agreement with and compatible in precision to the most precise previous measurement.
By analyzing 6.32 fb − 1 of e+ e− annihilation data collected at the center-of-mass energies between 4.178 and 4.226 GeV with the BESIII detector, we determine the branching fraction of the leptonic decay D + s → τ + ντ, with τ+ → π + π0¯ντ, to be B D + s → τ + ν τ = (5.29 ± 0.25 stat ± 0.20 syst) %. We estimate the product of the Cabibbo-Kobayashi-Maskawa matrix element |Vcs|and the D + s decay constant f D + s to be f D + s|Vcs| = (244.8 ± 5.8 stat ± 4.8syst) MeV, using the known values of the τ + and D + s masses as well as the D + s lifetime, together with our branching fraction measurement. Combining the value of |Vcs| obtained from a global fit in the standard model and f D + s from lattice quantum chromodynamics, we obtain f D + s = (251.6 ± 5.9 stat ± 4.9syst) MeV and |Vcs| = 0.980 ± 0.023 stat ± 0.019 syst. Using the branching fraction of B D + s → μ + νμ = (5.35±0.21)×10−3, we obtain the ratio of the branching fractions B D + s → τ + ντ/B D +s → μ+νμ = 9.89±0.71, which is consistent with the standard model prediction of lepton flavor universality.
Seven different instruments and measurement methods were used to examine the immersion freezing of bacterial ice nuclei from Snomax® (hereafter Snomax), a product containing ice active protein complexes from non-viable Pseudomonas syringae bacteria. The experimental conditions were kept as similar as possible for the different measurements. Of the participating instruments, some examined droplets which had been made from suspensions directly, and the others examined droplets activated on previously generated Snomax particles, with particle diameters of mostly a few hundred nanometers and up to a few micrometers in some cases. Data were obtained in the temperature range from −2 to −38 °C, and it was found that all ice active protein complexes were already activated above −12 °C. Droplets with different Snomax mass concentrations covering 10 orders of magnitude were examined. Some instruments had very short ice nucleation times down to below 1 s, while others had comparably slow cooling rates around 1 K min−1. Displaying data from the different instruments in terms of numbers of ice active protein complexes per dry mass of Snomax, nm, showed that within their uncertainty the data agree well with each other as well as to previously reported literature results. Two parameterizations were taken from literature for a direct comparison to our results, and these were a time dependent approach based on a contact angle distribution Niedermeier et al. (2014) and a modification of the parameterization presented in Hartmann et~al.~(2013) representing a time independent approach. The agreement between these and the measured data were good, i.e. they agreed within a temperature range of 0.6 K or equivalently a range in nm of a factor of 2. From the results presented herein, we propose that Snomax, at least when carefully shared and prepared, is a suitable material to test and compare different instruments for their accuracy of measuring immersion freezing.
Seven different instruments and measurement methods were used to examine the immersion freezing of bacterial ice nuclei from Snomax® (hereafter Snomax), a product containing ice-active protein complexes from non-viable Pseudomonas syringae bacteria. The experimental conditions were kept as similar as possible for the different measurements. Of the participating instruments, some examined droplets which had been made from suspensions directly, and the others examined droplets activated on previously generated Snomax particles, with particle diameters of mostly a few hundred nanometers and up to a few micrometers in some cases. Data were obtained in the temperature range from −2 to −38 °C, and it was found that all ice-active protein complexes were already activated above −12 °C. Droplets with different Snomax mass concentrations covering 10 orders of magnitude were examined. Some instruments had very short ice nucleation times down to below 1 s, while others had comparably slow cooling rates around 1 K min−1. Displaying data from the different instruments in terms of numbers of ice-active protein complexes per dry mass of Snomax, nm, showed that within their uncertainty, the data agree well with each other as well as to previously reported literature results. Two parameterizations were taken from literature for a direct comparison to our results, and these were a time-dependent approach based on a contact angle distribution (Niedermeier et al., 2014) and a modification of the parameterization presented in Hartmann et al. (2013) representing a time-independent approach. The agreement between these and the measured data were good; i.e., they agreed within a temperature range of 0.6 K or equivalently a range in nm of a factor of 2. From the results presented herein, we propose that Snomax, at least when carefully shared and prepared, is a suitable material to test and compare different instruments for their accuracy of measuring immersion freezing.
Background: Juvenile dermatomyositis (JDM) is the most common inflammatory myopathy in childhood and a major cause of morbidity among children with pediatric rheumatic diseases. The management of JDM is very heterogeneous. The JDM working group of the Society for Pediatric Rheumatology (GKJR) aims to define consensus- and practice-based strategies in order to harmonize diagnosis, treatment and monitoring of JDM.
Methods: The JDM working group was established in 2015 consisting of 23 pediatric rheumatologists, pediatric neurologists and dermatologists with expertise in the management of JDM. Current practice patterns of management in JDM had previously been identified via an online survey among pediatric rheumatologists and neurologists. Using a consensus process consisting of online surveys and a face-to-face consensus conference statements were defined regarding the diagnosis, treatment and monitoring of JDM. During the conference consensus was achieved via nominal group technique. Voting took place using an electronic audience response system, and at least 80% consensus was required for individual statements.
Results: Overall 10 individual statements were developed, finally reaching a consensus of 92 to 100% regarding (1) establishing a diagnosis, (2) case definitions for the application of the strategies (moderate and severe JDM), (3) initial diagnostic testing, (4) monitoring and documentation, (5) treatment targets within the context of a treat-to-target strategy, (6) supportive therapies, (7) explicit definition of a treat-to-target strategy, (8) various glucocorticoid regimens, including intermittent intravenous methylprednisolone pulse and high-dose oral glucocorticoid therapies with tapering, (9) initial glucocorticoid-sparing therapy and (10) management of refractory disease.
Conclusion: Using a consensus process among JDM experts, statements regarding the management of JDM were defined. These statements and the strategies aid in the management of patients with moderate and severe JDM.
We report a measurement of the observed cross sections of e+ e− → J/ψX based on 3.21 fb − 1 of data accumulated at energies from 3.645 to 3.891 GeV with the BESIII detector operated at the BEPCII collider. In analysis of the cross sections, we measured the decay branching fractions of B(ψ(3686) → J/ψX) = (64.4 ± 0.6 ± 1.6)% and B(ψ(3770) → J/ψX) = (0.5 ± 0.2 ± 0.1)% for the first time. The energy-dependent line shape of these cross sections cannot be well described by two Breit-Wigner (BW) amplitudes of the expected decays ψ (3686) → J/ψX and ψ(3770) → J/ψX. Instead, it can be better described with one more BW amplitude of the decay R(3760)→ J/ψX. Under this assumption, we extracted the R (3760) mass M R (3760 ) = 3766.2 ± 3.8 ± 0.4 MeV/c2, total width Γ tot R ( 3760 ) = 22.2 ± 5.9 ± 1.4 MeV, and product of leptonic width and decay branching fraction
ΓeeR(3760) B[R(3760) → J/ψX] = (79.4 ± 85.5 ± 11.7) eV. The significance of the R(3760) is 5.3σ. The first uncertainties of these measured quantities are from fits to the cross sections and second systematic.
Background: Since sorafenib has shown activity in different tumour types and gemcitabine regimens improved the outcome for biliary tract cancer (BTC) patients, we evaluated first-line gemcitabine plus sorafenib in a double-blind phase II study.
Patients and methods: 102 unresectable or metastatic BTC patients with histologically proven adenocarcinoma of gallbladder or intrahepatic bile ducts, Eastern Cooperative Oncology Group (ECOG) 0–2 were randomised to gemcitabine (1000 mg/m2 once weekly, first 7-weeks + 1-week rest followed by once 3-weeks + 1-week rest) plus sorafenib (400 mg twice daily) or placebo. Treatment continued until progression or unacceptable toxicity. Tumour samples were prospectively stained for sorafenib targets and potential biomarkers. Serum samples (first two cycles) were measured for vascular endothelial growth factors (VEGFs), vascular endothelial growth factor receptor 2 (VEGFR-2) and stromal cell-derived factor 1 (SDF1)α by enzyme-linked immunosorbent assay (ELISA).
Results: Gemcitabine plus sorafenib was generally well tolerated. Four and three patients achieved partial responses in the sorafenib and placebo groups, respectively. There was no difference in the primary end-point, median progression-free survival (PFS) for gemcitabine plus sorafenib versus gemcitabine plus placebo (3.0 versus 4.9 months, P = 0.859), and no difference for median overall survival (OS) (8.4 versus 11.2 months, P = 0.775). Patients with liver metastasis after resection of primary BTC survived longer with sorafenib (P = 0.019) compared to placebo. Patients who developed hand-foot syndrome (HFS) showed longer PFS and OS than patients without HFS. Two sorafenib targets, VEGFR-2 and c-kit, were not expressed in BTC samples. VEGFR-3 and Hif1α were associated with lymph node metastases and T stage. Absence of PDGFRβ expression correlated with longer PFS.
Conclusion: The addition of sorafenib to gemcitabine did not demonstrate improved efficacy in advanced BTC patients. Biomarker subgroup analysis suggested that some patients might benefit from combined treatment.
Using 7.33 fb−1 of e+e− collision data collected by the BESIII detector at center-of-mass energies between 4.128 and 4.226~GeV, we observe for the first time the decay D±s→ωπ±η with a statistical significance of 7.6σ. The measured branching fraction of this decay is (0.54±0.12±0.04)%, where the first uncertainty is statistical and the second is systematic.
Using a sample of (10.09±0.04)×109 J/ψ events collected with the BESIII detector, a partial wave analysis of J/ψ→γη′η′ is performed.The masses and widths of the observed resonances and their branching fractions are reported. The main contribution is from J/ψ→γf0(2020) with f0(2020)→η′η′, which is found with a significance of greater than 25σ. The product branching fraction B(J/ψ → γf0(2020))⋅B(f0(2020) → η′η′ is measured to be (2.63±0.06(stat.) + 0.31−0.46(syst.))×10−4.
We present the first experimental search for the rare charm decay D0→π0ν¯ν. It is based on an e+e− collision sample consisting of 10.6×10^6 pairs of D0¯D0 mesons collected by the BESIII detector at √s=3.773 GeV, corresponding to an integrated luminosity of 2.93 fb^−1. A data-driven method is used to ensure the reliability of the background modeling. No significant D0→π0ν¯ν signal is observed in data and an upper limit of the branching fraction is set to be 2.1×10^-4 at the 90% confidence level. This is the first experimental constraint on charmed-hadron decays into dineutrino final states.
Using data samples collected with the BESIII detector operating at the BEPCII storage ring at center-of-mass energies from 4.178 to 4.600 GeV, we study the process eþe− → π0Xð3872Þγ and search for Zcð4020Þ0 → Xð3872Þγ. We find no significant signal and set upper limits on σðeþe− → π0Xð3872ÞγÞ · BðXð3872Þ → πþπ−J=ψÞ and σðeþe− → π0Zcð4020Þ0Þ · BðZcð4020Þ0 → Xð3872ÞγÞ · BðXð3872Þ → πþπ−J=ψÞ for each energy point at 90% confidence level, which is of the order of several tenths pb.
We measure the inclusive semielectronic decay branching fraction of the D+s meson. A double-tag technique is applied to e+e− annihilation data collected by the BESIII experiment at the BEPCII collider, operating in the center-of-mass energy range 4.178–4.230 GeV. We select positrons fromD+s→Xe+νe with momenta greater than 200 MeV/c and determine the laboratory momentum spectrum, accounting for the effects of detector efficiency and resolution. The total positron yield and semielectronic branching fraction are determined by extrapolating this spectrum below the momentum cutoff. We measure the D+s semielectronic branching fraction to be(6.30±0.13(stat.)±0.09(syst.)±0.04(ext.))%, showing no evidence for unobserved exclusive semielectronic modes. We combine this result with external data taken from literature to determine the ratio of the D+s and D0 semielectronic widths, Γ(D+s→Xe+νe)Γ(D0→Xe+νe)=0.790±0.016(stat.)±0.011(syst.)±0.016(ext.). Our results are consistent with and more precise than previous measurements.
Investigators in the cognitive neurosciences have turned to Big Data to address persistent replication and reliability issues by increasing sample sizes, statistical power, and representativeness of data. While there is tremendous potential to advance science through open data sharing, these efforts unveil a host of new questions about how to integrate data arising from distinct sources and instruments. We focus on the most frequently assessed area of cognition - memory testing - and demonstrate a process for reliable data harmonization across three common measures. We aggregated raw data from 53 studies from around the world which measured at least one of three distinct verbal learning tasks, totaling N = 10,505 healthy and brain-injured individuals. A mega analysis was conducted using empirical bayes harmonization to isolate and remove site effects, followed by linear models which adjusted for common covariates. After corrections, a continuous item response theory (IRT) model estimated each individual subject’s latent verbal learning ability while accounting for item difficulties. Harmonization significantly reduced inter-site variance by 37% while preserving covariate effects. The effects of age, sex, and education on scores were found to be highly consistent across memory tests. IRT methods for equating scores across AVLTs agreed with held-out data of dually-administered tests, and these tools are made available for free online. This work demonstrates that large-scale data sharing and harmonization initiatives can offer opportunities to address reproducibility and integration challenges across the behavioral sciences.
The Born cross sections and effective form factors for process 𝑒+𝑒−→Ξ−¯Ξ+ are measured at eight center-of-mass energies between 2.644 and 3.080 GeV, using a total integrated luminosity of 363.9 pb−1 𝑒+𝑒− collision data collected with the BESIII detector at BEPCII. After performing a fit to the Born cross section of 𝑒+𝑒−→Ξ−¯Ξ+, no significant threshold effect is observed.
The electromagnetic process is studied with the initial-state-radiation technique using 7.5 fb−1 of data collected by the BESIII experiment at seven energy points from 3.773 to 4.600 GeV. The Born cross section and the effective form factor of the proton are measured from the production threshold to 3.0 GeV/ using the invariant-mass spectrum. The ratio of electric and magnetic form factors of the proton is determined from the analysis of the proton-helicity angular distribution.
By using 6.32 fb−1 of data collected with the BESIII detector at center-of-mass energies between 4.178 and 4.226 GeV, we perform an amplitude analysis of the decay D+s ! K0S + 0 and determine the relative fractions and phase differences of different intermediate processes, which include K0S (770)+, K0S (1450)+, K (892)0 +, K (892)+ 0, and K (1410)0 +. With the detection efficiency based on the amplitude analysis results, the absolute branching fraction is measured to be B(D+s ! K0S + 0) = (5.43 ± 0.30stat ± 0.15syst) × 10−3.
Relative fractions and phases of the intermediate decays are determined. With the detection efficiency estimated by the results of the amplitude analysis, the branching fraction of Dþ s → K−Kþπþπ0 decay is measured to be ð5.42 0.10stat 0.17systÞ%.
Based on an e+e− collision data sample corresponding to an integrated luminosity of 2.93 fb−1 collected with the BESIII detector at √s=3.773 GeV, the first amplitude analysis of the singly Cabibbo-suppressed decay D+→K+K0Sπ0 is performed. From the amplitude analysis, the K∗(892)+K0S component is found to be dominant with a fraction of (57.1±2.6±4.2)%, where the first uncertainty is statistical and the second systematic. In combination with the absolute branching fraction B(D+→K+K0Sπ0) measured by BESIII, we obtain B(D+→K∗(892)+K0S)=(8.69±0.40±0.64±0.51)×10−3, where the third uncertainty is due to the branching fraction B(D+→K+K0Sπ0). The precision of this result is significantly improved compared to the previous measurement. This result also differs from most of theoretical predictions by about 4σ, which may help to improve the understanding of the dynamics behind.
We report the first measurements of the absolute branching fractions of D0 → K0 Lϕ, D0 → K0Lη, D0 → K0Lω, and D0 → K0Lη0, by analyzing 2.93 fb−1 of eþe− collision data taken at a center-of-mass energy of 3.773 GeV with the BESIII detector. Taking the world averages of the branching fractions of D0 → K0Sϕ, D0 → K0Sη, D0 → K0Sω, and D0 → K0Sη0, the K0S − K0L asymmetries RðD0; XÞ in these decay modes are obtained. The CP asymmetries in these decays are also determined. No significant CP violation is observed